These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 7810008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Intensive immunosuppression in multiple sclerosis.
    Zaffaroni M, Ghezzi A, Comi G.
    Neurol Sci; 2006 Mar; 27 Suppl 1():S13-7. PubMed ID: 16708175
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Guidelines for drug treatment of multiple sclerosis].
    Kollegger H, Vass K, Marschall I, Koch G, Deecke L.
    Wien Klin Wochenschr; 1993 Mar; 105(16):443-52. PubMed ID: 7692677
    [Abstract] [Full Text] [Related]

  • 5. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982 Mar; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
    Stuart WH.
    Curr Med Res Opin; 2007 Jun; 23(6):1199-208. PubMed ID: 17559719
    [Abstract] [Full Text] [Related]

  • 7. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G, Antonello RM, Zorzon M, Torre P, Zivadinov R, Moretti R, Bragadin LM, De Masi R, Nasuelli D.
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [Abstract] [Full Text] [Related]

  • 8. [Immunosuppressive medication in multiple sclerosis].
    García Merino JA.
    Rev Neurol; 1999 Oct; 35(12):1154-8. PubMed ID: 12497298
    [Abstract] [Full Text] [Related]

  • 9. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC, Hartung HP.
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [Abstract] [Full Text] [Related]

  • 10. [Non-specific immunosuppression and multiple sclerosis].
    Brochet B.
    Rev Neurol (Paris); 1998 Sep; 154(8-9):629-34. PubMed ID: 9809379
    [Abstract] [Full Text] [Related]

  • 11. The peculiar difficulties of therapeutic trials for multiple sclerosis.
    Myers LW, Ellison GW.
    Neurol Clin; 1990 Feb; 8(1):119-41. PubMed ID: 1690838
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
    Edan G, Coustans M.
    Pathol Biol (Paris); 2000 Mar; 48(2):114-20. PubMed ID: 10815287
    [Abstract] [Full Text] [Related]

  • 14. [Recent therapeutic strategy for multiple sclerosis].
    Itoyama Y.
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1214-7. PubMed ID: 12235841
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].
    Achiron A, Miron S.
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S41-4. PubMed ID: 10896988
    [Abstract] [Full Text] [Related]

  • 18. Non-specific immunosuppressants in the treatment of multiple sclerosis.
    Confavreux C, Vukusic S.
    Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781
    [Abstract] [Full Text] [Related]

  • 19. Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome.
    Danieli MG, Cappelli M, Malcangi G, Logullo F, Salvi A, Danieli G.
    Ann Rheum Dis; 2004 Dec; 63(12):1649-54. PubMed ID: 15547090
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of multiple sclerosis--1. New drugs may be effective but there still are frequent relapses].
    Svenningsson A, Andersson M, Olsson T.
    Lakartidningen; 1998 Dec 02; 95(49):5623-7, 5630. PubMed ID: 9863300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.